Long-term use of zonisamide in refractory childhood-onset epilepsy

European Journal of Paediatric Neurology

Volumn 12, Issue 1, 2008, Pages 19-23

  Kluger, Gerhard ^a   Zsoter, Andrea ^a   Holthausen, Hans ^a  

^a Klinik fur Neuropadiatrie und Neurologische Rehabilitation   (Germany)

Author keywords

Childhood; Epilepsy; Long term use; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADD ON THERAPY; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BEHAVIOR CHANGE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONSTIPATION; DISABLED PERSON; DISEASE FREE INTERVAL; DRUG CAPSULE; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPTIC STATE; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; LONG TERM CARE; MAINTENANCE DRUG DOSE; MALE; MENTAL DEFICIENCY; NAUSEA; OBSERVATION; PRIORITY JOURNAL; SEIZURE AGGRAVATION; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; ISOXAZOLES; MALE; MYOCLONIC EPILEPSY, JUVENILE; RETROSPECTIVE STUDIES; TIME;

EID: 37149038509     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2007.05.003     Document Type: Article

References (18)

1. Arzimanoglou A., and Rahbani A. Zonisamide for the treatment of epilepsy. Expert Rev Neurother 6 9 (2006) 1283-1292
2. Rock D.M., Macdonald R.L., and Taylor C.P. Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, Cl912), a novel anticonvulsant. Epilepsy Res 3 (1989) 138-143
3. Kito M., Maehara M., and Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 5 (1996) 115-119
4. Kawai M., Hiramatsu M., Eno A., et al. Effect of zonisamide on release of aspartic acid and gamma-aminobutyric acid from hippocampal slices of E1 mice. Neuroscience 20 (1994) 115-119
5. Glauser T.A., and Pellock J.M. Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neurol 17 (2002) 87-96
6. Yagi K. Overview of Japanese experience-controlled and uncontrolled trials. Seizure 13S (2004) S11-S15
7. Sackellares J.C., Ramsay R.E., Wilder B.J., Browne III T.R., and Shellenberger M.K. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 45 (2004) 610-617
8. Schmidt D., Jacob R., Loiseau P., et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 15 (1993) 67-73
9. Faught E., Ayala R., Montouris G.G., and Leppik I.E. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 (2001) 1774-1779
10. Kothare S.V., Kaleyias J., Mostofi N., et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol 34 (2006) 351-354
11. Miura H. Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies. Seizure 13S (2004) S17-S23
12. Seki T., Kumagai N., and Maezawa M. Effects of zonisamide monotherapy in children with epilepsy. Seizure 13S (2004) S26-S32
13. Kim H.L., Aldridge J., and Rho J.M. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. J Child Neurol 20 3 (2005) 212-219
14. Oguni H., Hayashi K., Fukuyama Y., et al. Open clinical phase III trial of new antiepileptic drug zonisamide for childhood epilepsy [Alt. title: Phase III clinical study of the new antiepileptic drug AD-810 (zonisamide) in patients with childhood epilepsy]. Shonika Rinsho 41 (1988) 439-450 [in Japanese]
15. Tosches W.A., and Nagle K.J. Zonisamide use in status epilepticus [Poster] (December 2002), American Epilepsy Society, Seattle, WA, USA
16. Loscher W., and Schmidt D. Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 47 8 (2006) 1253-1284
17. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 8 (2004) 1252-1273
18. Santos C.C., and Brotherton T. Use of zonisamide in pediatric patients. Pediatr Neurol 33 (2005) 12-14